Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neurometabolic Effects of the Essential Polyunsaturated Fatty Acids in Early-Onset Bipolar Disorder: A Magnetic Resonance Spectroscopy Study

NCT00586222 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT00586222
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00586222 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neurometabolic Effects of the Essential Polyunsaturated Fatty Acids in Early-Onset Bipolar Disorder: A Magnetic Resonance Spectroscopy Study
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2007
Completion date
March 31, 2010
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adolescent bipolar disorder, magnetic resonance spectroscopy imaging, omega-3 fatty acids, pediatric bipolar disorder